/

/

Share this news:

Share this news:

Scientists Pinpoint Biological Cause of Long COVID Brain Fog

Scientists Pinpoint Biological Cause of Long COVID Brain Fog

Japanese researchers have identified increased brain receptor density as a key cause of cognitive impairment in Long COVID patients, offering new paths for diagnosis and treatment.

Scientific diagram showing effects of Long COVID on neurological pathways, suitable for illustrating biological basis of brain fog.

Source:

Nature

A Biological Cause for Brain Fog is Found

Scientists in Japan have discovered a definitive biological cause for the "brain fog" experienced by many Long COVID patients, according to a study published in Brain Communications. The research provides the first molecular evidence linking the debilitating cognitive symptom to measurable changes in the brain.

The groundbreaking study reveals that patients with Long COVID brain fog have a widespread increase in AMPA receptor density in their brains. These receptors are critical for memory and learning.

This discovery validates the condition as a legitimate, diagnosable medical issue, ending the uncertainty faced by millions. "This is a significant step forward," said lead researcher Prof. Takuya Takahashi of Yokohama City University. It offers a clear target for both diagnosis and future treatments.

Keep up with the story. Subscribe to the PR+ free daily newsletter

High quality clinical brain scan image from a peer-reviewed study on Long COVID-related cognitive symptoms.

Source:

The Lancet

Advanced Imaging Reveals Brain Changes

A Novel PET Scan Technique

To uncover the mystery, the research team employed a novel Positron Emission Tomography (PET) imaging technique. They used a specialized radiotracer, [11C]K-2, designed to bind specifically to AMPA receptors.

This allowed them to visualize and quantify the density of these receptors in the brains of 30 Long COVID patients and compare them to 80 healthy individuals.

What Are AMPA Receptors?

AMPA receptors are proteins on the surface of neurons that are fundamental to synaptic plasticity—the brain's ability to strengthen or weaken connections. As explained by the National Institute of Neurological Disorders and Stroke (NINDS), this process is essential for forming memories and learning new information. An abnormal density can disrupt these critical cognitive functions.

Clear Correlation Found

The study's results were conclusive:

  • Long COVID patients showed a notable and widespread increase in AMPA receptor density.

  • The severity of this increase directly correlated with the severity of patients' cognitive impairment.

  • Higher receptor levels were also linked to markers of inflammation in the body.

Detailed medical visualization showing brain imaging differences in Long COVID patients, with professional-grade resolution.

Source:

AuntMinnie

New Hope for Diagnosis and Treatment

A Reliable Diagnostic Tool

The PET imaging method proved highly effective, distinguishing Long COVID patients from healthy controls with 100% sensitivity and 91% specificity. This establishes it as a robust biomarker and a potential diagnostic tool for a condition that has been notoriously difficult to objectively measure.

This finding supports the ongoing efforts by public health bodies like the Centers for Disease Control and Prevention (CDC) to define and address Post-COVID Conditions.

Targeted Therapeutic Strategies

The discovery also illuminates a path toward treatment. Since elevated AMPA receptor density appears to cause the cognitive symptoms, drugs that suppress or modulate these receptors could be effective therapies.

While no such treatments are currently approved for Long COVID, this research provides a clear and promising target for future pharmaceutical development, potentially accelerating relief for those affected.

New Hope for Diagnosis and Treatment

A Reliable Diagnostic Tool

The PET imaging method proved highly effective, distinguishing Long COVID patients from healthy controls with 100% sensitivity and 91% specificity. This establishes it as a robust biomarker and a potential diagnostic tool for a condition that has been notoriously difficult to objectively measure.

This finding supports the ongoing efforts by public health bodies like the Centers for Disease Control and Prevention (CDC) to define and address Post-COVID Conditions.

Targeted Therapeutic Strategies

The discovery also illuminates a path toward treatment. Since elevated AMPA receptor density appears to cause the cognitive symptoms, drugs that suppress or modulate these receptors could be effective therapies.

While no such treatments are currently approved for Long COVID, this research provides a clear and promising target for future pharmaceutical development, potentially accelerating relief for those affected.

How does the increase in AMPA receptors contribute to cognitive impairment in Long COVID patients?

The study, published in *Brain Communications*, shows a direct correlation between the rise in AMPA receptor density and the severity of cognitive impairment. This suggests the altered receptor levels, potentially driven by inflammation, disrupt normal brain signaling essential for memory and learning, leading to brain fog.

How does the increase in AMPA receptors contribute to cognitive impairment in Long COVID patients?

The study, published in *Brain Communications*, shows a direct correlation between the rise in AMPA receptor density and the severity of cognitive impairment. This suggests the altered receptor levels, potentially driven by inflammation, disrupt normal brain signaling essential for memory and learning, leading to brain fog.

How does the increase in AMPA receptors contribute to cognitive impairment in Long COVID patients?

The study, published in *Brain Communications*, shows a direct correlation between the rise in AMPA receptor density and the severity of cognitive impairment. This suggests the altered receptor levels, potentially driven by inflammation, disrupt normal brain signaling essential for memory and learning, leading to brain fog.

What are the potential therapeutic targets identified by the study?

What are the potential therapeutic targets identified by the study?

What are the potential therapeutic targets identified by the study?

How does the new PET imaging technique work to visualize AMPA receptors?

How does the new PET imaging technique work to visualize AMPA receptors?

How does the new PET imaging technique work to visualize AMPA receptors?

What are the implications of these findings for diagnosing Long COVID?

What are the implications of these findings for diagnosing Long COVID?

What are the implications of these findings for diagnosing Long COVID?

How does the study's finding compare to previous research on Long COVID?

How does the study's finding compare to previous research on Long COVID?

How does the study's finding compare to previous research on Long COVID?

Share this news: